AA
SPPI

AlphaMark Advisors’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

AlphaMark Advisors’s Portfolio SPPI Stock Details SPPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-100
Closed -$2K – 518
2018
Q3 		$2K Hold
100
– – ﹤0.01% 479
2018
Q2 		$2K Hold
100
– – ﹤0.01% 493
2018
Q1 		$2K Hold
100
– – ﹤0.01% 483
2017
Q4 		$2K Buy
+100
New +$1.81K ﹤0.01% 482

Other funds holding SPPI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

AlphaMark Advisors's SPPI Position: Q4 2018 in Review

AlphaMark Advisors sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q4 2018, closing a stake of 100 shares — an estimated $2K sold.

AlphaMark Advisors first reported a position in SPPI in Q4 2017 and held it in 4 quarters. The position peaked at $2K in Q3 2018. 176 funds tracked by Wall St. Rank hold SPPI as of Q4 2018.

  • AlphaMark Advisors reported no remaining Spectrum Pharmaceuticals Inc position as of Q4 2018 after selling out during the quarter.
  • AlphaMark Advisors sold 100 Spectrum Pharmaceuticals Inc shares in Q4 2018, an estimated $2K.
  • AlphaMark Advisors first reported a position in Spectrum Pharmaceuticals Inc in Q4 2017 and held it in 4 quarters.
  • AlphaMark Advisors's Spectrum Pharmaceuticals Inc position peaked at $2K in Q3 2018.
  • 176 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q4 2018.

Based on AlphaMark Advisors's 13F filing for Q4 2018, filed 6 Feb 2019.